| Page 59 | Rogel Cancer Center | University of Michigan

Clinical Trial of Axitinab Successful for Patients with Head and Neck Cancer When first- and second-line treatments have been exhausted, few options remain for patients with advanced head and neck cancer. A new phase 2 clinical trial by researchers at the University of Michigan Rogel Cancer Center found the drug axitinib was able to extend the lives of these patients by several months, and also identified a subset of patients with a specific mutation for whom the drug is likely to work best. Read more about Clinical Trial of Axitinab Successful for Patients with Head and Neck Cancer	Referencing Support Grant and Shared Resources Whenever publishing about research supported by the Cancer Center Support Grant and/or our Shared Resources, please use the following: Referencing the Cancer Center Support Grant Research reported in this publication was supported by the National Cancer Institute under Award Number P30 CA046592. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Read more about Referencing Support Grant and Shared Resources	Maria Jose Silveira MD Read more about Maria Jose Silveira MD	Hope K Haefner MD Read more about Hope K Haefner MD
Megan Elizabeth Shelton MD Read more about Megan Elizabeth Shelton MD	Two Rogel Cancer Center members elected to National Academy of Medicine Today, F. DuBois Bowman, Justin B. Dimick, Christopher R. Friese, Karin M. Muraszko and Henry L. Paulson join a select group of fewer than 60 current and emeritus U-M faculty, and living former faculty, in the National Academy of Medicine. Drs. Friese and Muraszko are cancer center members. Read more about Two Rogel Cancer Center members elected to National Academy of Medicine	Yasmin H Karimi MD Read more about Yasmin H Karimi MD	Family History and Genetic Risk A small subset of cancers arise because a person has inherited one copy of a particular gene that does not work properly. It's important to understand your family history of cancer. Read more about Family History and Genetic Risk
New Research Highlights Disparity in Inflammatory Cancer Survival Rates Survival rates for women with inflammatory breast cancer have nearly doubled, but analysis shows an ongoing disparity between the survival rates of white patients and Black patients. Read more about New Research Highlights Disparity in Inflammatory Cancer Survival Rates	Ovarian Cancer Initiative at Michigan Medicine Receives Bequest The Ovarian Cancer Initiative at Michigan Medicine has received a generous bequest from Beth J. Johnson. It is the culmination of her dedicated efforts and extensive volunteer work for the initiative Read more about Ovarian Cancer Initiative at Michigan Medicine Receives Bequest

Referencing the Cancer Center Support Grant

A small subset of cancers arise because a person has inherited one copy of a particular gene that does not work properly. It's important to understand your family history of cancer.

Pages